Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

927
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
927
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.5K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.5K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

15
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trefoil polymers from a knotted synthon.

Nature chemistry·2026
Same author

Perspectives on Cannabis Use among Cancer Survivors and Cancer Care Providers: Parallel Surveys.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Symmetry-Protected Acoustic "Ghost Tunnels".

Physical review letters·2026
Same author

Increased risk of venous thromboembolism in children and teenagers with inflammatory bowel disease: a systematic review and meta-analysis.

PeerJ·2026
Same author

Assessment of Intraspecific Diversity and Screening of Elite Genotypes of <i>Atriplex canescens</i> as a Host Plant for <i>Cistanche deserticola</i>.

Plants (Basel, Switzerland)·2026
Same author

Waist circumference as a mediator in the association between sarcopenia and cognitive function.

Journal of Alzheimer's disease : JAD·2026

Related Experiment Video

Updated: Mar 24, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

656

Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.

Changqing Xu1, Douglas J Hermes1, Ken Mackie2

  • 1Department of Psychology & Neuroscience, University of North Carolina Chapel Hill, Chapel Hill, NC, 27599, USA.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|March 20, 2016
PubMed
Summary
This summary is machine-generated.

HIV-1 Tat impairs brain function by reducing inhibitory neurotransmission. Cannabinoids, acting via CB1 receptors, can block this effect, offering potential treatments for HIV-1-associated neurocognitive disorders (HAND).

Keywords:
CalciumCannabinoidCannabinoid 1 receptorGABA neurotransmissionHIV-1 TatPrefrontal cortex

More Related Videos

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

804

Related Experiment Videos

Last Updated: Mar 24, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

656
Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

804

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Molecular Biology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) infection targets the central nervous system, leading to HIV-1-associated neurocognitive disorders (HAND) despite combined antiretroviral therapy (cART).
  • Endocannabinoids possess neuroprotective qualities, yet their role in mitigating HAND-related neurological deficits remains largely unexplored.

Purpose of the Study:

  • To investigate the impact of HIV-1 Tat protein on GABAergic neurotransmission in the mouse prefrontal cortex.
  • To determine the role of cannabinoid receptors, specifically CB1R, in mediating the effects of endocannabinoids on neuronal function in the context of HIV-1 Tat exposure.

Main Methods:

  • Whole-cell recordings were conducted on young C57BL/6J mouse prefrontal cortex slices.
  • The study examined the effects of synthetic cannabinoid WIN55,212-2 and endocannabinoid anandamide (AEA) on inhibitory postsynaptic currents (IPSCs) in the presence of varying concentrations of HIV-1 Tat protein.
  • Pharmacological tools including CB1R antagonist rimonabant and CB2R antagonist AM630 were used to elucidate receptor involvement.

Main Results:

  • HIV-1 Tat significantly decreased the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSCs) in a dose-dependent manner.
  • Both WIN55,212-2 and AEA reduced IPSC frequency and occluded the further suppressive effects of Tat, indicating a shared pathway.
  • The cannabinoid 1 receptor (CB1R) antagonist rimonabant blocked the effects of Tat and cannabinoids on IPSCs, highlighting the critical role of CB1R.

Conclusions:

  • HIV-1 Tat impairs GABAergic neurotransmission through a mechanism involving CB1R.
  • Endocannabinoids, acting through CB1R, can counteract Tat-induced neurotoxicity.
  • Targeting the endocannabinoid system via CB1R presents a potential therapeutic strategy for managing cognitive impairments associated with HAND.